Retinal neovascularization Clinical Trials
Conditions / Retinal neovascularization
Delta Trials catalogs 13 clinical trials for Retinal neovascularization in its publicly accessible dataset. Within this set, 1 currently recruiting participants and 7 trials have reached completion. This research occurs across 16 participating sites around the world. An additional 5 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 1 trial were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
13
Total Trials
1
Recruiting
7
Completed
5
Other Active
1
Terminated since 2020
16
Study Locations
Browse by location (16 total)
- Boston, United States 3 trialsAll trials in Boston, United States
- Bern, Switzerland 2 trialsAll trials in Bern, Switzerland
- Baltimore, United States 2 trialsAll trials in Baltimore, United States
- St. Louis, United States 2 trialsAll trials in St. Louis, United States
- St. Louis, United States 2 trialsAll trials in St. Louis, United States
- Paris, France 1 trialAll trials in Paris, France
- Paris, France 1 trialAll trials in Paris, France
- Florence, United States 1 trialAll trials in Florence, United States
- Ghent, Belgium 1 trialAll trials in Ghent, Belgium
- Beirut, Lebanon 1 trialAll trials in Beirut, Lebanon
- Ribeirão Preto, Brazil 1 trialAll trials in Ribeirão Preto, Brazil
- Ribeirão Preto, Brazil 1 trialAll trials in Ribeirão Preto, Brazil
- Strasbourg, France 1 trialAll trials in Strasbourg, France
- Iaşi, Romania 1 trialAll trials in Iaşi, Romania
- Iaşi, Romania 1 trialAll trials in Iaşi, Romania
- Nedlands, Australia 1 trialAll trials in Nedlands, Australia
- Worcester, United States 1 trialAll trials in Worcester, United States
- Slingerlands, United States 1 trialAll trials in Slingerlands, United States
- Lyon, France 1 trialAll trials in Lyon, France
- Isfahan, Iran 1 trialAll trials in Isfahan, Iran